enVVeno Medical NVNO Stock
enVVeno Medical Price Chart
enVVeno Medical NVNO Financial and Trading Overview
| enVVeno Medical stock price | 4.99 USD |
| Previous Close | 2.77 USD |
| Open | 2.81 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 2.81 - 2.94 USD |
| 52 Week Range | 2.51 - 7.93 USD |
| Volume | 13.72K USD |
| Avg. Volume | 40.76K USD |
| Market Cap | 27.47M USD |
| Beta (5Y Monthly) | 1.252112 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.91 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NVNO Valuation Measures
| Enterprise Value | -6332560 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.3242009 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.80488485 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.242 |
Trading Information
enVVeno Medical Stock Price History
| Beta (5Y Monthly) | 1.252112 |
| 52-Week Change | -19.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.93 USD |
| 52 Week Low | 2.51 USD |
| 50-Day Moving Average | 3.83 USD |
| 200-Day Moving Average | 5.31 USD |
NVNO Share Statistics
| Avg. Volume (3 month) | 40.76K USD |
| Avg. Daily Volume (10-Days) | 43.77K USD |
| Shares Outstanding | 9.47M |
| Float | 8.6M |
| Short Ratio | 5.69 |
| % Held by Insiders | 0.54% |
| % Held by Institutions | 29.02% |
| Shares Short | 291.02K |
| Short % of Float | 3.08% |
| Short % of Shares Outstanding | 3.07% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.32% |
| Return on Equity (ttm) | -60.22% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -26179000 USD |
| Net Income Avi to Common (ttm) | -25731000 USD |
| Diluted EPS (ttm) | -2.4 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 34.21M USD |
| Total Cash Per Share (mrq) | 3.61 USD |
| Total Debt (mrq) | 1.64M USD |
| Total Debt/Equity (mrq) | 4.8 USD |
| Current Ratio (mrq) | 29.579 |
| Book Value Per Share (mrq) | 3.603 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17407000 USD |
| Levered Free Cash Flow (ttm) | -7598250 USD |
Profile of enVVeno Medical
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 70 Doppler |
| ZIP | 92618 |
| Phone | 949 261 2900 |
| Website | https://www.envveno.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 30 |
enVVeno Medical Corporation, a clinical med-tech company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of chronic venous disease. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Q&A For enVVeno Medical Stock
What is a current NVNO stock price?
enVVeno Medical NVNO stock price today per share is 4.99 USD.
How to purchase enVVeno Medical stock?
You can buy NVNO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for enVVeno Medical?
The stock symbol or ticker of enVVeno Medical is NVNO.
Which industry does the enVVeno Medical company belong to?
The enVVeno Medical industry is Medical Devices.
How many shares does enVVeno Medical have in circulation?
The max supply of enVVeno Medical shares is 13.32M.
What is enVVeno Medical Price to Earnings Ratio (PE Ratio)?
enVVeno Medical PE Ratio is now.
What was enVVeno Medical earnings per share over the trailing 12 months (TTM)?
enVVeno Medical EPS is -1.91 USD over the trailing 12 months.
Which sector does the enVVeno Medical company belong to?
The enVVeno Medical sector is Healthcare.
enVVeno Medical NVNO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}